-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
SVB Leerink Lowers Centogene (NASDAQ:CNTG) Price Target to $6.00
SVB Leerink Lowers Centogene (NASDAQ:CNTG) Price Target to $6.00
Centogene (NASDAQ:CNTG – Get Rating) had its price objective lowered by stock analysts at SVB Leerink from $10.00 to $6.00 in a research report issued to clients and investors on Monday, Stock Target Advisor reports. The firm presently has an "outperform" rating on the stock. SVB Leerink's price objective suggests a potential upside of 172.73% from the stock's previous close.
Centogene Trading Up 0.9 %
NASDAQ:CNTG opened at $2.20 on Monday. The firm has a market cap of $43.69 million, a PE ratio of -0.91 and a beta of -0.95. The stock has a fifty day moving average price of $2.61 and a 200 day moving average price of $3.58. Centogene has a 12-month low of $1.83 and a 12-month high of $11.75.
Get Centogene alerts:Institutional Inflows and Outflows
A hedge fund recently bought a new stake in Centogene stock. DekaBank Deutsche Girozentrale purchased a new stake in Centogene (NASDAQ:CNTG – Get Rating) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 16,319 shares of the company's stock, valued at approximately $67,000. DekaBank Deutsche Girozentrale owned approximately 0.08% of Centogene at the end of the most recent reporting period.
Centogene Company Profile
(Get Rating)Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Further Reading
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
Centogene (NASDAQ:CNTG – Get Rating) had its price objective lowered by stock analysts at SVB Leerink from $10.00 to $6.00 in a research report issued to clients and investors on Monday, Stock Target Advisor reports. The firm presently has an "outperform" rating on the stock. SVB Leerink's price objective suggests a potential upside of 172.73% from the stock's previous close.
據Stock Target Advisor報道,週一,SVB Leerink的股票分析師將Centogene(納斯達克:CNTG-GET評級)的目標價從10.00美元下調至6.00美元。該公司目前對該股的評級為“跑贏大盤”。SVB Leerink的目標股價顯示,該股較前一交易日收盤價可能上漲172.73%。
Centogene Trading Up 0.9 %
Centogene交易上漲0.9%
NASDAQ:CNTG opened at $2.20 on Monday. The firm has a market cap of $43.69 million, a PE ratio of -0.91 and a beta of -0.95. The stock has a fifty day moving average price of $2.61 and a 200 day moving average price of $3.58. Centogene has a 12-month low of $1.83 and a 12-month high of $11.75.
納斯達克:中旅集團週一開盤報2.2美元。該公司市值為4,369萬美元,市盈率為-0.91,貝塔係數為-0.95。該股的50日移動均價為2.61美元,200日移動均價為3.58美元。Centogene的12個月低點為1.83美元,12個月高位為11.75美元。
Institutional Inflows and Outflows
機構資金流入和流出
A hedge fund recently bought a new stake in Centogene stock. DekaBank Deutsche Girozentrale purchased a new stake in Centogene (NASDAQ:CNTG – Get Rating) during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 16,319 shares of the company's stock, valued at approximately $67,000. DekaBank Deutsche Girozentrale owned approximately 0.08% of Centogene at the end of the most recent reporting period.
一家對衝基金最近購買了Centogene股票的新股份。根據德意志銀行提交給美國證券交易委員會(美國證券交易委員會)的最新13F文件,德意志銀行在第一季度購買了Centogene(美國證券交易委員會:CNTG-GET Rating)的新股份。該公司購買了16,319股該公司股票,價值約67,000美元。在最近的報告期結束時,DekaBank Deutsche Girozentrale擁有Centogene約0.08%的股份。
Centogene Company Profile
Centogene公司簡介
Centogene N.V., together with its subsidiaries, focuses on rare diseases that transforms real-world clinical and genetic, or other data into actionable information for patients, physicians, and pharmaceutical companies worldwide. It operates through three segments: Pharmaceutical, Diagnostics, and COVID-19 testing.
Centogene N.V.及其子公司專注於罕見疾病,將現實世界的臨牀和基因或其他數據轉換為可操作的信息,供世界各地的患者、醫生和製藥公司使用。它通過三個部門運作:製藥、診斷和新冠肺炎測試。
Further Reading
進一步閲讀
- Get a free copy of the StockNews.com research report on Centogene (CNTG)
- Financial services firm Block stock has fallen (-59%) in 2022
- Hold Pfizer Today With Catalysts for Further Growth Tomorrow
- NVIDIA Stock is a Winding Up for a Record Setting Second Half
- Johnson & Johnson Continues to Prove its Value in a Volatile Year
- MarketBeat: Week in Review 7/11 – 7/15
- 免費獲取StockNews.com關於Centogene的研究報告(CNTG)
- 金融服務公司Block股價在2022年下跌(-59%)
- 今天持有輝瑞公司的催化劑,明天就能實現進一步增長
- NVIDIA股票將在下半年創下紀錄
- 強生在動盪的一年裏繼續證明自己的價值
- MarketBeat:回顧一週7/11-7/15
Receive News & Ratings for Centogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centogene and related companies with MarketBeat.com's FREE daily email newsletter.
接受《世紀英文報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Centogene和相關公司的最新新聞和分析師評級的每日簡要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧